Asia Pacific Molecular Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Disease Area (Infectious Disease, Oncology, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), By Technology(Polymerase Chain Reaction (PCR), In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing and Next-Generation Sequencing (NGS), DNA Microarrays, and, Others), By Type(RT-PCR, qPCR, Multiplex PCR, and Others), By Product and Services(Assays and Kits, Instruments, Services and Software), and By End User(Diagnostic Laboratories, Hospitals, and Clinics, Research and Academic Institutes, and Others)

Code: TIPRE00026008 | Pages: 302 | Industry: Biotechnology | Date: Nov 2021 | Type: Regional

The Molecular Diagnostics market in the Asia Pacific is expected to grow from US$ 3,072.95million in 2021 to US$ 7,488.57million by 2028; it is estimated to grow at a CAGR of 13.6% from 2021 to 2028.

 

Asia Pacific molecular diagnostics has wide application in various indications such as Oncology, Infectious disease, Genetic testing, Cardiac diseases, Immune system disorders, others. The increasing prevalence of the associated indications is expected to drive the market. For instance, cancer is one of the leading causes of death worldwide. The early detection of cancer can prevent death among the patients. POC diagnostics play an essential role in the early role and monitoring of cancer. The World Health Organization (WHO) stated that about 70% of deaths in low- and middle-income countries were caused by cancer in September 2021. In addition, as per the Global Burden of Disease Study in the Global Health Data Exchange and the World Health Statistics 2020 Cardiovascular Disease (CVD) mortality in China 322 per 100,000 population, India has reported 185 per 100,000 population of an early stage of CVD.  Thus, the rising prevalence of target diseases in Asia Pacific Molecular Diagnostics is expected to drive the market.

 

Countries in the Asia Pacific are facing challenges due to increasing incidences of COVID-19. As per the data of World meter, as of March 16, 2021, China reported a total of 90,066 COVID-19 cases, while in Japan it stood at 448,688, India recorded 11,438,734 cases, South Korea recorded 96,849 cases and Australia reported 29,151 confirmed cases. The shrinking economy of many countries is also going to affect many sectors including pharmaceuticals. As per the Asian Development Bank (ADB), a group of 45 countries in the Asia-Pacific region, is expected to post growth of just 0.1 per cent in 2020. The spread of the pandemic coupled with uncertainty around economic recovery has affected the pharmaceutical industry in the region. This economic impact is expected to have a negative effect on investments in research and development. However, the focus on the treatment of coronavirus is expected to offer new avenues for the point of care diagnostics. Some of the research institutes in the region are actively contributing to the research activities to check the feasibility for the management of coronavirus.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the molecular diagnostics sssmarket. The Asia Pacific Molecular Diagnostics market is expected to grow at a good CAGR during the forecast period.

 

Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2028(US$ Million)

Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2028(US$ Million)

Get more information on this report :

 

Asia Pacific Molecular Diagnostics Market Segmentation           

 

By Disease Area

  • Infectious Disease
  • Oncology
  • Genetic Testing
  • Cardiac Diseases
  • Immune System Disorders
  • Others

By Technology

  • Polymerase Chain Reaction (PCR)
  • In Situ Hybridization
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • DNA Sequencing and Next-Generation Sequencing (NGS)
  • DNA Microarrays
  • Others
  •  

By Type

  • RT-PCR
  • qPCR
  • Multiplex PCR
  • Others

 

By Product & Services

  • Assays and Kits
  • Instruments
  • Services and Software

 

By End User

  • Diagnostic Laboratories
  • Hospitals and Clinics
  • Research and Academic Institutes
  • Others

By Country

  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Malaysia
    • Thailand
    • Singapore
    • Philippines
    • Vietnam
    • Indonesia
    • Rest of Asia Pacific

 

Companies Mentioned -

  1. Abbott,
  2. Agilent Technologies, Inc.,
  3. Thermo Fisher Scientific Inc.,
  4. F. Hoffmann-La Roche Ltd.,
  5. TBG Diagnostics Limited,
  6. QIAGEN,
  7. bioMérieux SA,
  8. Siemens Healthineers AG,
  9. Illumina, Inc.,
  10. Danaher,
  11. Novartis AG.

 

1.        Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Molecular Diagnostics Market – By Disease Area

1.3.2        Asia Pacific Molecular Diagnostics Market – By Technology

1.3.3        Asia Pacific Molecular Diagnostics Market – By Product and Services

1.3.4        Asia Pacific Molecular Diagnostics Market – By End User

1.3.5        Asia Pacific Molecular Diagnostics Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.         Asia Pacific Molecular Diagnostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Asia Pacific PEST Analysis

4.3         Experts Opinion

5.           Asia Pacific Molecular Diagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increase in Demand for Point-of-Care and Developments by Market Players

5.1.2        Increasing Prevalence of Associated Diseases

5.2         Market Restraints

5.2.1        Limitations Associated the Molecular Testing

5.3         Market Opportunities

5.3.1        Global and Regional Players to Explore Untapped Markets for Potential Opportunities

5.4         Future Trends

5.4.1        Increasing Popularity of At-home Healthcare Services

5.5         Impact Analysis

6.           Asia Pacific Molecular Diagnostics Market–Country Analysis

6.1         Asia Pacific Molecular Diagnostics Market Revenue Forecast and Analysis

6.2         Asia Pacific Molecular Diagnostics Market – By Country Forecast and Analysis – 2020- 2028

7.           Asia Pacific Molecular Diagnostics Market Analysis – By Disease Area

7.1         Overview

7.2         Asia Pacific Molecular Diagnostics Market Revenue Share, by Disease Area (2020 and 2028)

7.3         Oncology

7.3.1        Overview

7.3.2        Oncology: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Infectious Disease

7.4.1        Overview

7.4.2        Infectious Disease: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Genetic Testing

7.5.1        Overview

7.5.2        Genetic Testing: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Cardiac Diseases

7.6.1        Overview

7.6.2        Cardiac Diseases: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7         Immune System Disorders

7.7.1        Overview

7.7.2        Immune System Disorders: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.8         Others

7.8.1        Overview

7.8.2        Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Asia Pacific Molecular Diagnostics Market– By Technology

8.1         Overview

8.2         Asia Pacific Molecular Diagnostics Market Revenue Share, by Technology (2020 and 2028)

8.3         Polymerase Chain Reaction (PCR)

8.3.1        Overview

8.3.2        Polymerase Chain Reaction (PCR): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.1          RT-PCR

8.3.2.1.1          Overview

8.3.2.1.2          RT-PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.2          qPCR

8.3.2.2.1          Overview

8.3.2.2.2          qPCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.3          Multiplex PCR

8.3.2.3.1          Overview

8.3.2.3.2          Multiplex PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.4          Others

8.3.2.4.1          Overview

8.3.2.4.2          Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Isothermal Nucleic Acid Amplification Technology (INAAT)

8.4.1        Overview

8.4.2        Isothermal Nucleic Acid Amplification Technology (INAAT): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5         DNA Sequencing and Next-Generation Sequencing (NGS)

8.5.1        Overview

8.5.2        DNA Sequencing and Next-Generation Sequencing: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6         DNA Microarrays

8.6.1        Overview

8.6.2        DNA Microarrays: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.7         In-Situ Hybridization (ISH)

8.7.1        Overview

8.7.2        In-Situ Hybridization: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.8         Others

8.8.1        Overview

8.8.2        Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Asia Pacific Molecular Diagnostics Market– by Product and Services

9.1         Overview

9.2         Asia Pacific Molecular Diagnostics Market, By Product and Services, 2020 & 2028 (%)

9.3         Assays and Kits

9.3.1        Overview

9.3.2        Assays and Kits: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

9.4         Instruments

9.4.1        Overview

9.4.2        Instruments: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

9.5         Services and Software

9.5.1        Overview

9.5.2        Services and Software: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.        Asia Pacific Molecular Diagnostics Market Revenue and Forecasts To 2028 – End User

10.1      Overview

10.2      Asia Pacific Molecular Diagnostics Market Share by End User – 2020 & 2028 (%)

10.3      Hospitals and Clinics

10.3.1     Overview

10.3.2     Hospitals and Clinics: Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.4      Diagnostic Laboratories

10.4.1     Overview

10.4.2     Diagnostic Laboratories: Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.5      Research and Academic Institutes

10.5.1     Overview

10.5.2     Research and Academic Institutes: Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.6      Others

10.6.1     Overview

10.6.2     Others: Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.        Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 – Country Analysis

11.1. Asia Pacific

11.1.1     Overview

11.1.2     Asia Pacific: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3     Asia Pacific : Asia Pacific Molecular Diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

11.1.4     Asia Pacific : Asia Pacific Molecular Diagnostics Market, by Technology, 2019–2028 (US$ Million)

11.1.4.1       Asia Pacific : Polymerase Chain Reaction (PCR) Market, by Type, 2019–2028 (US$ Million)

11.1.5     Asia Pacific : Asia Pacific Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

11.1.6     Asia Pacific : Asia Pacific Molecular Diagnostics Market, by End User, 2019–2028 (US$ Million)

11.1.7     Asia Pacific Molecular Diagnostics Market Revenue Share, by Country (2021 and 2028)

11.1.7.1       India: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.1       Overview

11.1.7.1.2       India: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.3       India: Asia Pacific Molecular Diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

11.1.7.1.4       India: Asia Pacific Molecular Diagnostics Market, by Technology, 2019–2028 (US$ Million)

11.1.7.1.4.1     India: Polymerase Chain Reaction (PCR) Market, By Type, 2019–2028 (US$ Million)

11.1.7.1.5       India: Asia Pacific Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

11.1.7.1.6       India: Asia Pacific Molecular Diagnostics Market, by End User, 2019–2028 (US$ Million)

11.1.7.2       Singapore: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.1       Overview

11.1.7.2.2       Singapore: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.3       Singapore: Asia Pacific Molecular Diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

11.1.7.2.4       Singapore: Asia Pacific Molecular Diagnostics Market, by Technology, 2019–2028 (US$ Million)

11.1.7.2.4.1     Singapore: Polymerase Chain Reaction (PCR) Market, By Type, 2019–2028 (US$ Million)

11.1.7.2.5       Singapore: Asia Pacific Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

11.1.7.2.6       Singapore: Asia Pacific Molecular Diagnostics Market, by End User, 2019–2028 (US$ Million)

11.1.7.3       Philippines: Molecular Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.1       Overview

11.1.7.3.2       Philippines: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.3       Philippines: Asia Pacific Molecular Diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

11.1.7.3.4       Philippines: Asia Pacific Molecular Diagnostics Market, by Technology, 2019–2028 (US$ Million)

11.1.7.3.4.1     Philippines: Polymerase Chain Reaction (PCR) Market, By Type, 2019–2028 (US$ Million)

11.1.7.3.5       Philippines: Asia Pacific Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

11.1.7.3.6       Philippines: Asia Pacific Molecular Diagnostics Market, by End User, 2019–2028 (US$ Million)

11.1.7.4       Indonesia: Molecular Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.4.1       Overview

11.1.7.4.2       Indonesia: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.4.3       Indonesia: Asia Pacific Molecular Diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

11.1.7.4.4       Indonesia: Asia Pacific Molecular Diagnostics Market, by Technology, 2019–2028 (US$ Million)

11.1.7.4.4.1     Indonesia: Polymerase Chain Reaction (PCR) Market, By Type, 2019–2028 (US$ Million)

11.1.7.4.5       Indonesia: Asia Pacific Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

11.1.7.4.6       Indonesia: Asia Pacific Molecular Diagnostics Market, by End User, 2019–2028 (US$ Million)

11.1.7.5       Vietnam: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.5.1       Overview

11.1.7.5.2       Vietnam: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.5.3       Vietnam: Asia Pacific Molecular Diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

11.1.7.5.4       Vietnam: Asia Pacific Molecular Diagnostics Market, by Technology, 2019–2028 (US$ Million)

11.1.7.5.4.1     Vietnam: Polymerase Chain Reaction (PCR) Market, by Type, 2019–2028 (US$ Million)

11.1.7.5.5       Vietnam: Asia Pacific Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

11.1.7.5.6       Vietnam: Asia Pacific Molecular Diagnostics Market, by End User, 2019–2028 (US$ Million)

11.1.7.6       Thailand: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.6.1       Overview

11.1.7.6.2       Thailand: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.6.3       Thailand: Asia Pacific Molecular Diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

11.1.7.6.4       Thailand: Asia Pacific Molecular Diagnostics Market, by Technology, 2019–2028 (US$ Million)

11.1.7.6.4.1     Thailand: Polymerase Chain Reaction (PCR) Market, By Type, 2019–2028 (US$ Million)

11.1.7.6.5       Thailand: Asia Pacific Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

11.1.7.6.6       Thailand: Asia Pacific Molecular Diagnostics Market, by End User, 2019–2028 (US$ Million)

11.1.7.7       Malaysia : Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.7.1       Overview

11.1.7.7.2       Malaysia : Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.7.3       Malaysia : Asia Pacific Molecular Diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

11.1.7.7.4       Malaysia : Asia Pacific Molecular Diagnostics Market, by Technology, 2019–2028 (US$ Million)

11.1.7.7.4.1     Malaysia : Polymerase Chain Reaction (PCR) Market, by Type, 2019–2028 (US$ Million)

11.1.7.7.5       Malaysia : Asia Pacific Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

11.1.7.7.6       Malaysia : Asia Pacific Molecular Diagnostics Market, by End User, 2019–2028 (US$ Million)

11.1.7.8       Japan: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

11.1.7.8.1       Overview

11.1.7.8.2       Japan: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

11.1.7.8.3       Japan: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

11.1.7.8.4       Japan: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

11.1.7.8.4.1     Japan: Asia Pacific Molecular Diagnostics Market, by Type, 2019–2028 (US$ Million)

11.1.7.8.5       Japan: Asia Pacific Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

11.1.7.8.6       Japan: Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.1.7.9       China: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

11.1.7.9.1       Overview

11.1.7.9.2       China: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

11.1.7.9.3       China: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

11.1.7.9.4       China: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

11.1.7.9.4.1     China: Asia Pacific Molecular Diagnostics Market, by Type, 2019–2028 (US$ Million)

11.1.7.9.5       China: Asia Pacific Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

11.1.7.9.6       China: Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.1.7.10    South Korea: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

11.1.7.10.1    Overview

11.1.7.10.2    South Korea: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

11.1.7.10.3    South Korea: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

11.1.7.10.4    South Korea: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

11.1.7.10.4.1  South Korea: Asia Pacific Molecular Diagnostics Market, by Type, 2019–2028 (US$ Million)

11.1.7.10.5    South Korea: Asia Pacific Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028  (US$ Million)

11.1.7.10.6    South Korea: Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.1.7.11    Australia: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

11.1.7.11.1    Overview

11.1.7.11.2    Australia: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

11.1.7.11.3    Australia: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

11.1.7.11.4    Australia: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

11.1.7.11.4.1  Australia: Asia Pacific Molecular Diagnostics Market, by Type, 2019–2028 (US$ Million)

11.1.7.11.5    Australia: Asia Pacific Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

11.1.7.11.6    Australia: Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.1.7.12    Rest of Asia Pacific: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.12.1    Overview

11.1.7.12.2    Rest of Asia Pacific: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.12.3    Rest of Asia Pacific: Asia Pacific Molecular Diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

11.1.7.12.4    Rest of Asia Pacific: Asia Pacific Molecular Diagnostics Market, by Technology, 2019–2028 (US$ Million)

11.1.7.12.4.1  Rest of Asia Pacific: Polymerase Chain Reaction (PCR) Market, By Type, 2019–2028 (US$ Million)

11.1.7.12.5    Rest of Asia Pacific: Asia Pacific Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

11.1.7.12.6    Rest of Asia Pacific: Asia Pacific Molecular Diagnostics Market, by End User, 2019–2028 (US$ Million)

12.        Impact Of COVID-19 Pandemic on Asia Pacific Molecular Diagnostics Market

12.1. Asia-Pacific: Impact Assessment of COVID-19 Pandemic

13.        Asia Pacific Molecular Diagnostics Market–Industry Landscape

13.1      Overview

13.2      Growth Strategies Done by the Companies in the Market (%)

13.3      Organic Developments

13.3.1     Overview

13.4      Inorganic Developments

13.4.1     Overview

14.        Company Profiles

14.1      Abbott

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Agilent Technologies, Inc.

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      THERMO FISHER SCIENTIFIC INC.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      F. HOFFMANN-LA ROCHE LTD.

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      QIAGEN

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      bioMerieux SA

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      Illumina, Inc.

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      Danaher

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      Siemens Healthineers AG

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10   Novartis AG

14.10.1  Key Facts

14.10.2  Business Description

14.10.3  Products and Services

14.10.4  Financial Overview

14.10.5  SWOT Analysis

14.10.6  Key Developments

14.11   TBG Diagnostics Limited

14.11.1  Key Facts

14.11.2  Business Description

14.11.3  Products and Services

14.11.4  Financial Overview

14.11.5  SWOT Analysis

14.11.6  Key Developments

15.        Appendix

15.1      About the Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.             Asia Pacific Molecular Diagnostics Market, by Disease Area– Revenue and Forecast to 2028 (US$ Million)

Table 2.             Asia Pacific Molecular Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 3.             Asia Pacific : Polymerase Chain Reaction (PCR) Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Asia Pacific Molecular Diagnostics Market, by Product and Services– Revenue and Forecast to 2028 (US$ Million)

Table 5.             Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 6.             India Asia Pacific Molecular Diagnostics Market, by Disease Area – Revenue and Forecast to 2028 (US$ Million)

Table 7.             India Asia Pacific Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 8.             India Polymerase Chain Reaction (PCR) Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 9.             India Asia Pacific Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

Table 10.          India Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Singapore Asia Pacific Molecular Diagnostics Market, by Disease Area – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Singapore Asia Pacific Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Singapore Polymerase Chain Reaction (PCR) Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Singapore Asia Pacific Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028  (US$ Million)

Table 15.          Singapore Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Philippines Asia Pacific Molecular Diagnostics Market, by Disease Area – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Philippines Asia Pacific Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Philippines Polymerase Chain Reaction (PCR) Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Philippines Asia Pacific Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Philippines Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Indonesia Asia Pacific Molecular Diagnostics Market, by Disease Area – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Indonesia Asia Pacific Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 23.          Indonesia Polymerase Chain Reaction (PCR) Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Indonesia Asia Pacific Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Indonesia Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 26.          Vietnam Asia Pacific Molecular Diagnostics Market, by Disease Area– Revenue and Forecast to 2028 (US$ Million)

Table 27.          Vietnam Asia Pacific Molecular Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 28.          Vietnam: Polymerase Chain Reaction (PCR) Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 29.          Vietnam Asia Pacific Molecular Diagnostics Market, by Product and Services– Revenue and Forecast to 2028 (US$ Million)

Table 30.          Vietnam Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 31.          Thailand Asia Pacific Molecular Diagnostics Market, by Disease Area – Revenue and Forecast to 2028 (US$ Million)

Table 32.          Thailand Asia Pacific Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 33.          Thailand Polymerase Chain Reaction (PCR) Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 34.          Thailand Asia Pacific Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

Table 35.          Thailand Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 36.          Malaysia Asia Pacific Molecular Diagnostics Market, by Disease Area– Revenue and Forecast to 2028 (US$ Million)

Table 37.          Malaysia Asia Pacific Molecular Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 38.          Malaysia : Polymerase Chain Reaction (PCR) Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 39.          Malaysia Asia Pacific Molecular Diagnostics Market, by Product and Services– Revenue and Forecast to 2028 (US$ Million)

Table 40.          Malaysia: Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 41.          Japan: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

Table 42.          Japan: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 43.          Japan: Asia Pacific Molecular Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million

Table 44.          Japan: Asia Pacific Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

Table 45.          Japan: Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 46.          China: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

Table 47.          China: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 48.          China: Asia Pacific Molecular Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million

Table 49.          China: Asia Pacific Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

Table 50.          China: Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 51.          South Korea: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

Table 52.          South Korea: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 53.          South Korea: Asia Pacific Molecular Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million

Table 54.          South Korea: Asia Pacific Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

Table 55.          South Korea: Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 56.          Australia: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

Table 57.          Australia: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 58.          Australia: Asia Pacific Molecular Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million

Table 59.          Australia: Asia Pacific Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028  (US$ Million)

Table 60.          Australia: Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 61.          Rest of Asia Pacific Molecular Diagnostics Market, by Disease Area – Revenue and Forecast to 2028  (US$ Million)

Table 62.          Rest of Asia Pacific Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 63.          Rest of Asia Pacific Polymerase Chain Reaction (PCR) Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 64.          Rest of Asia Pacific Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

Table 65.          Rest of Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 66.          Organic Developments Done By Companies

Table 67.          Inorganic Developments Done By Companies

Table 68.          Glossary of Terms, Molecular Diagnostics Market

 

 

LIST OF FIGURES

Figure 1.           Asia Pacific Molecular Diagnostics Market Segmentation

Figure 2.           Asia Pacific Molecular Diagnostics Market Overview

Figure 3.           Infectious Disease Segment Held Largest Share of Disease Area Segment in Asia Pacific Molecular Diagnostics Market

Figure 4.           China is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Asia Pacific Molecular Diagnostics Market, Industry Landscape

Figure 6.           Asia Pacific: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Asia Pacific Molecular Diagnostics Market: Impact Analysis of Drivers and Restraints

Figure 9.           Asia Pacific Molecular Diagnostics Market Revenue Share, by Disease Area (2020 and 2028)

Figure 10.        Oncology: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Infectious Disease: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Genetic Testing: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Cardiac Diseases: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Immune System Disorders: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Asia Pacific Molecular Diagnostics Market Revenue Share, by Technology (2020 and 2028)

Figure 17.        Polymerase Chain Reaction (PCR): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        RT-PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        qPCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Multiplex PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Isothermal Nucleic Acid Amplification Technology (INAAT): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        DNA Sequencing and Next-Generation Sequencing: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        DNA Microarrays: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        In-Situ Hybridization: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Asia Pacific Molecular Diagnostics Market, by Product and Services, 2020 & 2028 (%)

Figure 28.        Asia Pacific Assays and Kits: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        Asia Pacific Instruments: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30.        Services and Software: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 31.        Asia Pacific Molecular Diagnostics Market Share by End User - 2020 & 2028 (%)

Figure 32.        Asia Pacific Hospitals and Clinics: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 33.        Diagnostic Laboratories: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 34.        Research and Academic Institutes: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 35.        Others: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 36.        Asia Pacific: Asia Pacific Molecular Diagnostics Market, by Key Country – Revenue (2020) (USD Million)

Figure 37.        Asia Pacific: Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Asia Pacific: Asia Pacific Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 39.        India: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40.        Singapore: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41.        Philippines: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42.        Indonesia: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43.        Vietnam: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44.        Thailand: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45.        Malaysia : Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46.        Japan: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 47.        China: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 48.        South Korea: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 49.        Australia: Asia Pacific Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 50.        Rest of Asia Pacific: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 51.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 52.        Growth Strategies Done by the Companies in the Market (%)

  1. Abbott,
  2. Agilent Technologies, Inc.,
  3. Thermo Fisher Scientific Inc.,
  4. F. Hoffmann-La Roche Ltd.,
  5. TBG Diagnostics Limited,
  6. QIAGEN,
  7. bioMérieux SA,
  8. Siemens Healthineers AG,
  9. Illumina, Inc.,
  10. Danaher,
  11. Novartis AG.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000